Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin - DeFronzo, R A; Lewin, A; Patel, S; Liu, D; Kaste, R; Woerle, H J; Broedl, U C (Diabetes Care, 2015)